Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Dooms

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Future Oncology (London, England)|December 17, 2021
INSIGHT 2: a phase II study of tepotinib plus osimertinib in <i>MET</i>-amplified NSCLC and first-line osimertinib resistanceEgbert F Smit, Christophe Dooms, Jo Raskin, et al.
Nature Communications|October 30, 2021
Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the hostVerónica Lloréns-Rico, Ann C Gregory, Johan Van Weyenbergh, et al.
Respirology (Carlton, Vic.)|June 27, 2025
World Association for Bronchology and Interventional Pulmonology (WABIP) Guidelines on Airway Stenting for Benign Central Airway ObstructionUdit Chaddha, Abhinav Agrawal, Septimiu Murgu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 22, 2026
Evaluation of [¹⁸F]AlF-NOTA-octreotide PET/CT in routine clinical use: a retrospective analysis in 288 neuroendocrine tumor patientsHannes Leupe, Sophie-Anne De Buyst, Jeroen Dekervel, et al.
The New England Journal of Medicine|June 5, 2023
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung CancerHeather Wakelee, Moishe Liberman, Terufumi Kato, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 20, 2024
Implementation of an enhanced recovery protocol for lung volume reduction surgery: an observational cohort studyChristelle M Vandervelde, Stephanie Everaerts, Walter Weder, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2024
A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancerDavid Planchard, Jürgen Wolf, Benjamin Solomon, et al.
JAMA|November 25, 2010
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trialJouke T Annema, Jan P van Meerbeeck, Robert C Rintoul, et al.
The European Respiratory Journal|December 23, 2017
Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre studyHerbert Decaluwé, Christophe Dooms, Xavier Benoit D'Journo, et al.
Lancet (London, England)|September 17, 2024
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trialJonathan D Spicer, Marina C Garassino, Heather Wakelee, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Future Oncology (London, England)|December 17, 2021
INSIGHT 2: a phase II study of tepotinib plus osimertinib in <i>MET</i>-amplified NSCLC and first-line osimertinib resistanceEgbert F Smit, Christophe Dooms, Jo Raskin, et al.
Nature Communications|October 30, 2021
Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the hostVerónica Lloréns-Rico, Ann C Gregory, Johan Van Weyenbergh, et al.
Respirology (Carlton, Vic.)|June 27, 2025
World Association for Bronchology and Interventional Pulmonology (WABIP) Guidelines on Airway Stenting for Benign Central Airway ObstructionUdit Chaddha, Abhinav Agrawal, Septimiu Murgu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 22, 2026
Evaluation of [¹⁸F]AlF-NOTA-octreotide PET/CT in routine clinical use: a retrospective analysis in 288 neuroendocrine tumor patientsHannes Leupe, Sophie-Anne De Buyst, Jeroen Dekervel, et al.
The New England Journal of Medicine|June 5, 2023
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung CancerHeather Wakelee, Moishe Liberman, Terufumi Kato, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 20, 2024
Implementation of an enhanced recovery protocol for lung volume reduction surgery: an observational cohort studyChristelle M Vandervelde, Stephanie Everaerts, Walter Weder, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2024
A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancerDavid Planchard, Jürgen Wolf, Benjamin Solomon, et al.
JAMA|November 25, 2010
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trialJouke T Annema, Jan P van Meerbeeck, Robert C Rintoul, et al.
The European Respiratory Journal|December 23, 2017
Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre studyHerbert Decaluwé, Christophe Dooms, Xavier Benoit D'Journo, et al.
Lancet (London, England)|September 17, 2024
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trialJonathan D Spicer, Marina C Garassino, Heather Wakelee, et al.
Pageof 14